Validation of BCR-ABL quantification for the follow-up of chronic myelocytic leukemia patients

被引：0
|
作者：
Laurence, Rozen [1 ]
Pierre, Heimann [1 ]
Philippe, Martiat [2 ]
Hakim, El Housni [1 ]
机构：
[1] Univ Libre Bruxelles, CUB Hosp Erasme, Dept Med Genet, Brussels, Belgium
[2] Univ Libre Bruxelles, Inst Jules Bordet, Dept Clin & Expt Hematol, Brussels, Belgium
来源：
ACTA CLINICA BELGICA | 2009年 / 64卷 / 02期
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：182 / 182
页数：1
相关论文
共 50 条
  • [21] BCR-ABL is not an immunodominant antigen in chronic myelogenous leukemia
    Gruenebach, Frank
    Mirakaj, Valbona
    Mirakaj, Valdete
    Mueller, Martin R.
    Bruemmendorf, Tim
    Brossart, Peter
    CANCER RESEARCH, 2006, 66 (11) : 5892 - 5900
  • [22] New BCR-ABL inhibitors in chronic myeloid leukemia
    Rea, Delphine
    ANNALS OF ONCOLOGY, 2019, 30
  • [23] BCR-ABL translocation in a dog with chronic monocytic leukemia
    Cardona, Janice A. Cruz
    Milner, Rowan
    Alleman, A. Rick
    Williams, Christina
    Vernau, William
    Breen, Matthew
    Tompkins, Mary
    VETERINARY CLINICAL PATHOLOGY, 2011, 40 (01) : 40 - 47
  • [24] Mutant BCR-ABL clones in chronic myeloid leukemia
    Mathisen, Michael S.
    Kantarjian, Hagop M.
    Cortes, Jorge
    Jabbour, Elias
    HAEMATOLOGICA-THE HEMATOLOGY JOURNAL, 2011, 96 (03): : 347 - 349
  • [25] Expression of μ-BCR-ABL transcripts in chronic neutrophilic leukemia
    Cioc, AM
    Nuovo, GJ
    AMERICAN JOURNAL OF CLINICAL PATHOLOGY, 2002, 118 (06) : 842 - 847
  • [26] ABSENCE OF BCR-ABL KINASE DOMAIN MUTATIONS IN CHRONIC MYELOCYTIC LEUKEMIA (CML) QATARI PATIENTS ON IMATINIB MESYLATE (IM) TREATMENT
    Al-Dewik, I.
    Jewell, P.
    Elayoubi, R.
    Morsi, M.
    HAEMATOLOGICA-THE HEMATOLOGY JOURNAL, 2010, 95 : 532 - 532
  • [27] Drug evaluation: Nilotinib - a novel Bcr-Abl tyrosine kinase inhibitor for the treatment of chronic myelocytic leukemia and beyond
    Jabbour, Elias
    Cortes, Jorge
    Giles, Francis
    O'Brien, Susan
    Kantarjian, Hagop
    IDRUGS, 2007, 10 (07) : 468 - 479
  • [28] Characterization of Bcr-Abl deletion mutants from patients with chronic myeloid leukemia
    Sherbenou, Daniel W.
    Hantschel, Oliver J.
    Turaga, Lalita
    Kaupe, Ines
    Willis, Stephanie
    Bumm, Thomas
    Press, Richard D.
    Superti-Furga, Giulio
    Druker, Brian J.
    Deininger, Michael W.
    BLOOD, 2007, 110 (11) : 862A - 863A
  • [29] Frequency of BCR-ABL fusion transcripts in Serbian patients with chronic myeloid leukemia
    Todoric-Zivanovic, B.
    Strnad, M.
    Stamatovic, D.
    Tukic, L.
    Krtolica, K.
    Tatomirovic, Z.
    Djordjevic, V.
    Bogdanovic, A.
    Jankovic, G.
    Magic, Z.
    JOURNAL OF BUON, 2011, 16 (01): : 104 - 107
  • [30] Frequency of BCR-ABL Fusion Transcripts in Saudi Patients with Chronic Myelogenous Leukemia
    Elbjeirami, W. M.
    Abdulwahab, A.
    Elsayed, H.
    Elnagdi, N.
    Abd Allatif, N.
    Al-Jedani, H.
    Al Shaikh, A.
    Al-Allaf, F. A.
    JOURNAL OF MOLECULAR DIAGNOSTICS, 2015, 17 (06): : 766 - 766
12345